Back to results
US 10,472,392 B2Granted
Macrocyclic inhibitors of flaviviridae viruses
AssigneesGilead Sciences, Inc., Cypralis Limited
InventorsCaroline Aciro, Jean Yves Chiva, David Kenneth Dean, Adrian John Highton, Petr Jansa, Andrew John Keats, Linos Lazarides, Richard Mackman, Karine G. Poullennec, Adam James Schrier, Dustin Scott Siegel, Victoria Alexandra Steadman, Greg Watt
Life of this patent
Estimating the term…
Abstract
Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.
Claims13
A compound of Formula I:
- or a pharmaceutically acceptable salt, isotope, stereoisomer, mixture of stereoisomers, tautomer, ester or prodrug thereof, wherein:
- A is CH2;
- A1 is (C2-C5)alkenylene, wherein a sp3 carbon atom of A1 is optionally replaced by —O—, —S(O)n—, —NH— or —N((C1-C4)alkyl)-, and wherein a sp3 or sp2 carbon atom of A1 is optionally substituted with one or more groups selected from the group consisting of halo, (C1-C5)alkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, aryl, heterocycloalkyl, cycloalkyl, aryl(C1-C4)alkyl, cycloalkyl(C1-C4)alkyl, heterocycloalkyl(C1-C4)alkyl, arylheterocycloalkyl(C1-C4)alkyl, —OR9, —SR9, —S(O)R9, —S(O)2R9 and —N(R9)2;
- A2 is —CH(R8)-heteroarylene, wherein A2 is optionally substituted with one or more substituents selected from the group consisting of —OR9, —SR9, —S(O)R9, —S(O)2R9, —N(R9)2, halo, halo(C1-C4)alkyl, halo(C1-C4)alkoxy, cyano and (C1-C8)alkyl;
- L1 is —O—C(O);
- X1 is —NH— or —N(CH3)—;
- R1 and R2, when taken together with the carbon to which they are both attached, form —C(═O)—;
- R3 is H or (C1-C4)alkyl optionally substituted with halo, cyano, hydroxyl or (C1-C4)alkoxy;
- R4a and R4b are independently H or (C1-C5)alkyl, wherein each R4a and R4b is optionally substituted with one or more substituents selected from the group consisting of cyano, —COOH, halo, hydroxyl, amino, (C1-C5)alkoxy, mono(C1-C5)alkylamino, di(C1-C5)alkylamino, aryl and heteroaryl;
- R5a and R5b are independently H or (C1-C5)alkyl optionally substituted with one or more substituents selected from the group consisting of —N3, cyano, —COOH, halo, hydroxyl, amino, mono(C1-C5)alkylamino, di(C1-C5)alkylamino, (C1-C5)alkoxy, aryl and heteroaryl, or
- R5a and R5b together form a spirocycle having Formula (a):
- wherein one or more carbon ring atoms of Formula (a) is optionally replaced by a nitrogen, oxygen or sulfur atom, and wherein a ring atom of Formula (a) optionally has one or more substituents selected from the group consisting of oxo, ═N(C1-C4)alkoxy, halo, hydroxyl, —NH2, (C1-C4)alkyl, halo(C1-C4)alkyl, (C1-C4)alkoxy, —OC(O)R9, —C(O)2R9, and —S(O)2R9;
- R6a and R6b together form a spirocycle having Formula (a);
- R8 is H, (C1-C4)alkyl, halo(C1-C4)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, aryl, heteroaryl, heterocycloalkyl or cycloalkyl, wherein R8 is optionally substituted with —OR, —N(R9)2, —CON(R9)2, or cyano;
- each R9 is independently H, (C1-C4)alkyl, halo(C1-C4)alkyl, (C2-C4)alkenyl or (C2-C4)alkynyl;
- and
- m is 1, 2, 3, 4 or 5.
14 more elements
A compound selected from:
Dependencies are inferred from the claim text.